Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia.
Jinfeng ZhangMingxi LinYizi JinLinhan GuTing LiBaoying YuanBiyun WangLeiping WangSheng ZhangJun CaoZhonghua TaoJian ZhangXichun HuPublished in: Breast cancer research and treatment (2020)
Cisplatin given at three divided doses with no hydration in MBC is a less toxic (less CINV and hypomagnesaemia) schedule with comparable efficacy. Thus, it may be a good alternative for one full-dose (75 mg/m2) schedule.